ReviewInfection & chemotherapy2020
Decision on Chemotherapy Amidst COVID-19 Pandemic: a Review and a Practical Approach from Iran.
Review in Infection & chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 25 citations in OpenAlex.
- Impact of the COVID-19 Pandemic on Cancer Management in Iran: A Review.Health science reports · 2026Article
- De novo myasthenia gravis in a patient with malignant melanoma after concurrent SARS-CoV-2 vaccination and immune checkpoint inhibitor therapy: Case report and literature review.eNeurologicalSci · 2024Article
- Application of artificial intelligence (AI) to control COVID-19 pandemic: Current status and future prospects.Heliyon · 2024Review
- Role of children in the Bulgarian COVID-19 epidemic: A mathematical model study.World journal of experimental medicine · 2023Article
- In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19.Human gene (Amsterdam, Netherlands) · 2023Article
- Impact of lockdown policies during the COVID-19 outbreak on a trauma center of a tertiary hospital in China.World journal of clinical cases · 2023Article
- The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland.Frontiers in public health · 2023Article
- Clinical Characteristics of Severe COVID-19 Patients During Omicron Epidemic and a Nomogram Model Integrating Cell-Free DNA for Predicting Mortality: A Retrospective Analysis.Infection and drug resistance · 2023Article
- COVID-19 Anxiety and Wellbeing at Work in Finland during 2020-2022: A 5-Wave Longitudinal Survey Study.International journal of environmental research and public health · 2022Article
- Reducing Virus Transmission from Heating, Ventilation, and Air Conditioning Systems of Urban Subways.Toxics · 2022Article
- COVID-19-associated disseminated mucormycosis: An autopsy case report.World journal of clinical cases · 2022Article
- Smile InHealthcare (Basel, Switzerland) · 2022Article
- Article
- Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.Therapeutics and clinical risk management · 2022Article
- COVID-19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case-controlled study from Iran.Cancer reports (Hoboken, N.J.) · 2021Article
- Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge.BMJ case reports · 2021Article
- Review on the Oncology Practice in the Midst of COVID-19 Crisis: The Challenges and Solutions.Asian Pacific journal of cancer prevention : APJCP · 2021Review
- Comparison of mortality in patients on chemotherapy or immunotherapy during and before COVID-19 pandemic. Multicenter matched cohort study in Argentina.Revista peruana de medicina experimental y salud publicaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To provide a step-by-step approach to chemotherapy (CTx) in the novel coronavirus disease 2019 (COVID-19) era. The COVID-19 pandemic is the current global issue resulting in vast health implications. Amid the COVID-19 era, special attention must be paid to at-risk groups, including patients with cancer. To our knowledge, there is a paucity of data on the decision for CTx during the pandemic. We herein provide practical recommendations on the CTx of cancer patients over the pandemic based on our experience in an educational hospital. The decision on CTx should be considered to be individualized based on clinical findings. We hope that our experience provides a practical guide for clinical oncologists to deliver more effective cancer care over the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.